Aristotle University Of Thessaloniki (AUTH)
Μελέτη της επίδρασης του ρετινοϊκού οξέος και αναστολέων των κυκλινοεξαρτώμενων κινασών στη διαφοροποίηση λευχαιμικών κυττάρων
Abstract
dc:descriptionAcute promyelocytic leukemia (APL) is characterized by chromosome translocations, which generate fusion oncogenic proteins that play critical roles in pathogenesis. Of these chromosomal translocations, the RARα gene is fused with the PML gene in frame to form a chimeric PML-RARα gene, which is expressed in over 95% of the patients with t(15; 17)q22;q21. APL cells also express the germ cell-specific Cyclin A1 protein, which also contributes to APL-like disease in mouse models. Retinoic acid (RA) induces relocalization and degradation of PML-RARα and has contributed to effective therapy for APL. However, pharmacologic levels of RA cause several serious side effects and its effectiveness is reduced. APL patients respond to pharmacologic levels of ATRA with myelodysplastic syndrome, cutaneous T-cell lymphoma and skin cancers. Recent evidence suggests that low doses of ATRA with other modalities, such as specific inhibitors of the CDK’s (CDKi's), e.g. Olomoucine, Roscovitine etc.), are equally efficacious with potentially reduced toxicity, for the treatment or prevention of cancer. Here, we demonstrate that combined use of low (sub-pharmacological) levels of ATRA/Olomoucine and ATRA/Roscovitine in NB4 cells leads to effective differentiation accompanied by reduction in CDK4 protein levels, lack of degradation of the fusion protein and upregulation of the transcription factor CEBP/ε.
Degree
thesis:*- Grantor dc:publisher
- Aristotle University Of Thessaloniki (AUTH)
- Year dc:date
- 2012
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Tsolkas, Grigorios
- Τσόλκας, Γρηγόριος
Subjects
dc:subject × 18- Οξεία προμυελοκυτταρική λευχαιμία
- Ολομουκίνη
- Ροσκοβιτίνη
- Διαφοροποίηση
- Κυκλινοεξαρτώμενες κινάσες
- Αναστολείς κυκλινοεξαρτωμένων κινασών
- Κυκλίνη Α1
- Acute promyelocytic leukemia
- Olomoucine
- Roscovitine
- Differentiation therapy
- Cyclin A1
- Cyclin dependent kinases
- Cyclin dependent kinase inhibitors
- Ιατρική και Επιστήμες Υγείας
- Βασική Ιατρική
- Medical and Health Sciences
- Basic Medicine
Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/28088